Provident Financial Services
PFS · NYSE
About PFS
- Employees
- 1,817
- Headquarters
- Jersey City, New Jersey
- Listed
- Jan 16, 2003
- Sector
- Financials
- Industry
- Banks
- Website
- provident.bank
PFS key statistics
- Market cap
- 2.94B
- Price-earnings ratio
- 9.21
- Dividend yield
- 4.23%
- Average volume
- 860.70K
- Volume
- 700.79K
- Open price
- $22.25
- High today
- $22.71
- Low today
- $22.25
- 52 Week high
- $25.49
- 52 Week low
- $17.72
Provident Financial Services (PFS) at a glance
Provident Financial Services (PFS) last traded at $22.53, with a market cap of 2.94B, a price-to-earnings ratio of 9.21 and a dividend yield of 4.23%.
Today the stock has traded between $22.25 and $22.71. The current price is 1.3% above the day's low and 0.8% below its high.
Volume so far is 700.79K shares, in line with the average of 860.70K shares a day.
Over the past year Provident Financial Services has ranged from $17.72 to $25.49, and now sits 62% of the way up that range.
Provident Financial Services met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.59 per share against an estimate of $0.5707.
The average analyst price target is $28.05, 24.5% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy60.0%
- Hold40.0%
- Sell0.0%
- Low
- $26.26
- Now
- $22.53
- High
- $31.50
PFS earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 6.8% on average.
- Q3 FY24: reported $0.36 per share against an estimate of $0.4767
- Q4 FY24: reported $0.37 per share against an estimate of $0.507
- Q1 FY25: reported $0.49 per share against an estimate of $0.4747
- Q2 FY25: reported $0.55 per share against an estimate of $0.5016
- Q3 FY25: reported $0.55 per share against an estimate of $0.5471
- Q4 FY25: reported $0.64 per share against an estimate of $0.5616
- Q1 FY26: reported $0.61 per share against an estimate of $0.5552
- Q2 FY26: reported $0.59 per share against an estimate of $0.5707
PFS news
- Press releasePRNewswire
A Look Ahead: Provident Finl Servs's Earnings Forecast
- Press releasePRNewswire
Peninsula Family Service, A Leading Nonprofit Organization Dedicated to Strengthening Communities Across the Peninsula, Announces Year-long Celebration of its 75th Anniversary
- Press releaseGlobe Newswire
Provident Financial Services, Inc. Reports Third Quarter Earnings and Declares Quarterly Cash Dividend
- Press releaseBusiness Wire
Provident Strengthens Healthcare Lending Team with the Addition of Vik Venkataraman as Senior Relationship Manager
Similar companies
Companies in the same industry as Provident Financial Services
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.